Condition: Postural Tachycardia Syndrome · Sponsor: University of Calgary
Objective: In this pilot study, we will test the hypothesis that patients with POTS (age 18-60 years) will have a higher percentage of functional antibodies to adrenergic receptors compared with control subjects without POTS.
This description comes directly from the study's public registry record.
Satish R Raj, MD, MSCI · 403-210-6152 · autonomic.research@ucalgary.ca
Robert S Sheldon, MD, PhD · 403-220-8191 · autonomic.research@ucalgary.ca
Always discuss trial participation with your own doctor first.
| University of Calgary | Calgary, Alberta, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02673996